Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Clin Cancer Res. 2015 Feb 4;21(9):2045–2056. doi: 10.1158/1078-0432.CCR-14-0921

Figure 3. Genomic lesion associations with response to induction chemotherapy.

Figure 3

Univariate analysis of median overall survival in the MI-All-AML (N=156) and MI-dnAML (N=103) subgroups based on type of response to therapy (A). Frequency of gene mutations and structural genomic aberrations, minimally amplified or deleted regions, and aCNA/cnLOH load stratified by response to treatment in (B) all cases or in (C) TP53 wildtype cases only.